These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29101272)

  • 1. Illness-associated muscle weakness in dystroglycanopathies.
    Carlson CR; McGaughey SD; Eskuri JM; Stephan CM; Zimmerman MB; Mathews KD
    Neurology; 2017 Dec; 89(23):2374-2380. PubMed ID: 29101272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the barriers to cardiac care in carriers of Duchenne and Becker muscular dystrophy.
    Eekhoff L; Edwards J; Martin A; Prijoles EJ
    J Genet Couns; 2019 Oct; 28(5):993-1002. PubMed ID: 31373078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(40):1119-22. PubMed ID: 19834452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of caregiving on women in families with Duchenne/Becker muscular dystrophy.
    Kenneson A; Bobo JK
    Health Soc Care Community; 2010 Sep; 18(5):520-8. PubMed ID: 20561071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.
    Yanagisawa A; Bouchet C; Van den Bergh PY; Cuisset JM; Viollet L; Leturcq F; Romero NB; Quijano-Roy S; Fardeau M; Seta N; Guicheney P
    Neurology; 2007 Sep; 69(12):1254-60. PubMed ID: 17634419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic delay in patients with FKRP-related muscular dystrophy.
    Coffey LN; Stephan CM; Zimmerman MB; Decker CK; Mathews KD
    Neuromuscul Disord; 2021 Dec; 31(12):1235-1240. PubMed ID: 34857438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POMT2 intragenic deletions and splicing abnormalities causing congenital muscular dystrophy with mental retardation.
    Yanagisawa A; Bouchet C; Quijano-Roy S; Vuillaumier-Barrot S; Clarke N; Odent S; Rodriguez D; Romero NB; Osawa M; Endo T; Taratuto AL; Seta N; Guicheney P
    Eur J Med Genet; 2009; 52(4):201-6. PubMed ID: 19138766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at onset of first signs or symptoms predicts age at loss of ambulation in Duchenne and Becker Muscular Dystrophy: Data from the MD STARnet.
    Ciafaloni E; Kumar A; Liu K; Pandya S; Westfield C; Fox DJ; Caspers Conway KM; Cunniff C; Mathews K; West N; Romitti PA; McDermott MP
    J Pediatr Rehabil Med; 2016; 9(1):5-11. PubMed ID: 26966795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies.
    Devisme L; Bouchet C; Gonzalès M; Alanio E; Bazin A; Bessières B; Bigi N; Blanchet P; Bonneau D; Bonnières M; Bucourt M; Carles D; Clarisse B; Delahaye S; Fallet-Bianco C; Figarella-Branger D; Gaillard D; Gasser B; Delezoide AL; Guimiot F; Joubert M; Laurent N; Laquerrière A; Liprandi A; Loget P; Marcorelles P; Martinovic J; Menez F; Patrier S; Pelluard F; Perez MJ; Rouleau C; Triau S; Attié-Bitach T; Vuillaumier-Barrot S; Seta N; Encha-Razavi F
    Brain; 2012 Feb; 135(Pt 2):469-82. PubMed ID: 22323514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genitourinary health in a population-based cohort of males with Duchenne and Becker Muscular dystrophies.
    Zhu Y; Romitti PA; Caspers Conway KM; Kim S; Zhang Y; Yang M; Mathews KD;
    Muscle Nerve; 2015 Jul; 52(1):22-7. PubMed ID: 25297835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study.
    Hoogerwaard EM; Bakker E; Ippel PF; Oosterwijk JC; Majoor-Krakauer DF; Leschot NJ; Van Essen AJ; Brunner HG; van der Wouw PA; Wilde AA; de Visser M
    Lancet; 1999 Jun; 353(9170):2116-9. PubMed ID: 10382696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.
    Yis U; Uyanik G; Heck PB; Smitka M; Nobel H; Ebinger F; Dirik E; Feng L; Kurul SH; Brocke K; Unalp A; Özer E; Cakmakci H; Sewry C; Cirak S; Muntoni F; Hehr U; Morris-Rosendahl DJ
    Neuromuscul Disord; 2011 Jan; 21(1):20-30. PubMed ID: 20961758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and electrophysiological evaluation of myasthenic features in an alpha-dystroglycanopathy cohort (FKRP-predominant).
    Gonzalez-Perez P; Smith C; Sebetka WL; Gedlinske A; Perlman S; Mathews KD
    Neuromuscul Disord; 2020 Mar; 30(3):213-218. PubMed ID: 32115343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and etiology of congenital muscular dystrophy.
    Peat RA; Smith JM; Compton AG; Baker NL; Pace RA; Burkin DJ; Kaufman SJ; Lamandé SR; North KN
    Neurology; 2008 Jul; 71(5):312-21. PubMed ID: 18160674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies.
    Endo T; Manya H; Seta N; Guicheney P
    Methods Enzymol; 2010; 479():343-52. PubMed ID: 20816175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.
    Mercuri E; Messina S; Bruno C; Mora M; Pegoraro E; Comi GP; D'Amico A; Aiello C; Biancheri R; Berardinelli A; Boffi P; Cassandrini D; Laverda A; Moggio M; Morandi L; Moroni I; Pane M; Pezzani R; Pichiecchio A; Pini A; Minetti C; Mongini T; Mottarelli E; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Vasco G; Santorelli FM; Bertini E
    Neurology; 2009 May; 72(21):1802-9. PubMed ID: 19299310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limb-girdle muscular dystrophy type 2I is not rare in Taiwan.
    Liang WC; Hayashi YK; Ogawa M; Wang CH; Huang WT; Nishino I; Jong YJ
    Neuromuscul Disord; 2013 Aug; 23(8):675-81. PubMed ID: 23800702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation of the fukutin gene causing late-onset limb girdle muscular dystrophy.
    Riisager M; Duno M; Hansen FJ; Krag TO; Vissing CR; Vissing J
    Neuromuscul Disord; 2013 Jul; 23(7):562-7. PubMed ID: 23746544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.